STAHIST AD
- Product NDC
- 58407-625
- 11-digit product format
- 584070625
- Labeler code
- 58407
- Product ID
- 58407-625_4041d3f9-d1cb-0931-e063-6394a90a82de
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- CHLORCYCLIZINE HYDROCHLORIDE and PSEUDOEPHEDRINE HYDROCHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Magna Pharmaceuticals, Inc.
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2011-12-20
- Substance
- CHLORCYCLIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
- Active strength
- 25; 60 mg/1; mg/1
- Pharmacologic classes
- Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded product | product | 86f5da6cb304… | a595104c45d7… | |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 58407-625-30 | 86f5da6cb304… | a595104c45d7… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 58407-625-06 | 86f5da6cb304… | a595104c45d7… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 58407-625-01 | 86f5da6cb304… | a595104c45d7… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded product | product | bd6a592717d7… | 303034d00443… | |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 58407-625-30 | bd6a592717d7… | 303034d00443… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 58407-625-06 | bd6a592717d7… | 303034d00443… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 58407-625-01 | bd6a592717d7… | 303034d00443… |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded product | product | 8dfbde2a14a4… | c9ff85d89658… | |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded package | package | 58407-625-30 | 8dfbde2a14a4… | c9ff85d89658… |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded package | package | 58407-625-06 | 8dfbde2a14a4… | c9ff85d89658… |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded package | package | 58407-625-01 | 8dfbde2a14a4… | c9ff85d89658… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- STAHIST AD
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| CHLORCYCLIZINE HYDROCHLORIDE | 25 mg/1 |
| PSEUDOEPHEDRINE HYDROCHLORIDE | 60 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| NPB7A7874U | Internal UNII lookup |
| 6V9V2RYJ8N | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| ccedbc38-2479-4c35-9f86-a9f29bcfab3f | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ba088a92-ab5e-b2d4-e908-f5ea691b7587 | Product name | 7 | 20210201 |
| 0fdb98e2-b951-a1ce-5715-2b187ba500ef | Product name | 4 | 20170718 |
| e974e22d-8688-7d92-1e87-40c1079e170c | Product name | 3 | 20151125 |
| e8718272-64cb-4436-969b-176c3067c8f4 | Product name | 1 | 20150609 |
| 30c51294-7ae9-8007-7de6-58222684a0be | Product name | 1 | 20140508 |
| 4f26f669-fc6c-40ef-9e26-1c7b2390ee66 | Product name | 1 | 20140508 |
| 70a83adc-6047-bbea-5a08-dfd304aa47d2 | Product name | 1 | 20140508 |
| 858ce051-9941-aafc-8c7c-44a8e0227463 | Product name | 1 | 20140508 |
| b893258d-0942-3d8a-3411-056ea0788ff5 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 58407-625-01 | 2023-11-06 | Stahist AD |
| 58407-625-06 | 2023-11-06 | Stahist AD |
| 58407-625-30 | 2023-11-06 | Stahist AD |
| 58407-625-01 | 2023-07-28 | Stahist AD |
| 58407-625-06 | 2023-07-28 | Stahist AD |
| 58407-625-30 | 2023-07-28 | Stahist AD |
| 58407-625-01 | 2022-08-17 | Stahist AD |
| 58407-625-06 | 2022-08-17 | Stahist AD |
| 58407-625-30 | 2022-08-17 | Stahist AD |
| 58407-625-01 | 2021-01-29 | Stahist AD |
| 58407-625-06 | 2021-01-29 | Stahist AD |
| 58407-625-30 | 2021-01-29 | Stahist AD |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 58407-625-01 | STAHIST AD | 1 in 1 BLISTER PACK | TABLET | 1 | 8 | |
| 58407-625-06 | STAHIST AD | 6 in 1 BOX | TABLET | 6 | 8 | |
| 58407-625-30 | STAHIST AD | 30 in 1 BOTTLE | TABLET | 30 | 8 | |
| 58407-625-30 | STAHIST AD | 1 in 1 BOX | TABLET | 1 | 8 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 58407-625-30 | EA - Each | 58407-625 | 1514b49e-4e09-4f4f-bcde-62b65472665c | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 58407-625 | STAHIST AD (CHLORCYCLIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE) TABLET [MAGNA PHARMACEUTICALS, INC.] | 7 | Current NDC, Legacy NDC, 4 package rows | 20241207_ccedbc38-2479-4c35-9f86-a9f29bcfab3f.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Allergy Relief | CHLORPHENIRAMINE MALEATE | Good Sense | f88e2654-8e97-4cf6-9c36-01aeb51a9102 | 2021-11-30 | Warnings | M012 |
| Cold Medicine | COLD MEDICINE | Allegiant Health | 443fbc44-2c33-4316-ad31-dcc5a5aa8f52 | 2021-11-23 | Warnings | M012 |
| Decongestant PE Non Drowsy | PHENYLEPHRINE HCL | Allegiant Health | 7a3098b4-381c-4f32-97a7-87b53fd64428 | 2021-06-16 | Warnings | M012 |
| Mucus Relief Immediate Release | GUAIFENESIN 400MG | Good Sense | e7c68746-7ec0-46cf-b4a3-174fab819b5e | 2021-05-05 | Warnings | M012 |
| Mucus Relief Immediate Release | GUAIFENESIN 400MG | TopCo Associates, LLC | 7d91c6ab-d161-42b9-b353-0aa8f59619f8 | 2021-01-21 | Warnings | M012 |
| Daytime Cold and Flu | ACETAMINOPHEN 325MG/ DEXTROMETHORPHAN HBR 10MG/ PHENYLEPHRINE HCL 5MG | Allegiant Health | bed5f9dc-45ea-4e90-86c6-86599b6f3861 | 2020-11-16 | Warnings | M012 |
| Nighttime Cold and Flu Relief | ACETAMINOPHEN | Allegiant Health | b97126d7-847d-483e-b3d1-e2b61ab1743f | 2020-11-11 | Warnings | M012 |
| Cold and Allergy | PHENYLEPHRINE HCL AND CHLORPHENIRAMINE MALEATE | Allegiant Health | 7af63769-fa56-4f1f-a2ad-5b4c108c8e4f | 2019-12-12 | Warnings | M012 |
| Mucus Relief Immediate Release | GUAIFENESIN | Allegiant Health | 221d64a2-b8c7-435a-aae4-fb58fd38108f | 2019-03-26 | Warnings | M012 |
| Sleep Tabs For Nighttime use | DIPHENHYDRAMINE HCL TABLETS | Allegiant Health | 566e40b1-e9d7-44e4-b971-eef2b7cf0a7d | 2018-12-26 | Warnings | M012 |
| Allergy | CHLORPHENIRAMINE MALEATE | Allegiant Health | 4305ad50-d2a5-4d3e-9d92-cbf26e856a16 | 2018-12-26 | Warnings | M012 |
| Sleep Aid | DIPHENHYDRAMINE HCL 25 MG | Allegiant Health | dbbc535f-515a-4d9b-b799-34e60f5230bb | 2018-12-21 | Warnings | M012 |
| Allergy | DIPHENHYDRAMINE HCL | Allegiant Health | c2823bad-540f-4662-8dcc-58e9f0d94efb | 2018-11-07 | Warnings | M012 |
| Nasal Decongestant PE Maximum Strength Non-Drowsy | PHENYLEPHRINE 10 MG | Allegiant Health | 7aef00df-816a-4ea2-a2ad-beed66dd2fe4 | 2018-11-07 | Warnings | M012 |
| DEXTROMETHORPHAN HYDROBROMIDE, Guaifenesin, and PHENYLEPHRINE HYDROCHLORIDE | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Westminster Pharmaceuticals, LLC | a58bfb14-28f9-4425-a5a5-aaff4847c979 | 2018-03-14 | Warnings | M012 |
| Chlorpheniramine maleate 4mg | CHLORPHENIRAMINE MALEATE 4MG | Athlete's Needs, Inc. | 4d974959-25fc-4707-9b72-9afbf47b76f1 | 2017-11-14 | Warnings | M012 |
| Cold Medicine | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL | Selder, S.A. de C.V. | d2762d9c-e7e7-42b2-a26a-14b2aa0307cb | 2017-01-25 | Warnings | M012 |
| Allergy | CHLORPHENIRAMINE MALEATE | Marc Glassman, Inc. | 2051247f-ce64-4cf5-b449-9ca14c43ab86 | 2016-12-27 | Warnings | M012 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1235861 | chlorcyclizine HCl 25 MG / pseudoephedrine HCl 60 MG Oral Tablet | PSN | ccedbc38-2479-4c35-9f86-a9f29bcfab3f | 8 |
| 1236716 | Stahist AD 25 MG / 60 MG Oral Tablet | PSN | ccedbc38-2479-4c35-9f86-a9f29bcfab3f | 8 |
| 1236716 | chlorcyclizine hydrochloride 25 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet [Stahist AD] | SBD | ccedbc38-2479-4c35-9f86-a9f29bcfab3f | 8 |
| 1235861 | chlorcyclizine hydrochloride 25 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet | SCD | ccedbc38-2479-4c35-9f86-a9f29bcfab3f | 8 |
| 1236716 | Stahist AD (chlorcyclizine hydrochloride 25 MG / pseudoephedrine hydrochloride 60 MG) Oral Tablet | SY | ccedbc38-2479-4c35-9f86-a9f29bcfab3f | 8 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 58407-625-01 | 58407062501 | 1 TABLET in 1 BLISTER PACK (58407-625-01) | 1 tablet | 2019-09-01 | 0000-00-00 | No | No | Current |
| 58407-625-06 | 58407062506 | 6 BLISTER PACK in 1 BOX (58407-625-06) / 1 TABLET in 1 BLISTER PACK (58407-625-01) | 6 blister pack | 2011-12-20 | 0000-00-00 | No | No | Current |
| 58407-625-30 | 58407062530 | 1 BOTTLE in 1 BOX (58407-625-30) / 30 TABLET in 1 BOTTLE | 1 bottle | 2011-12-20 | 0000-00-00 | No | No | Current |